Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT vs AAT After Lower Limb Revascularization
NCT04168398Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Jul 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in peripheral artery disease (PAD), sponsored by Mansoura University. Started Jul 2019; status: completed.
02
Drugs
apixaban
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04168398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168398.